|
2006.7.10 renewal |
WJTOG INTERNATIONAL LUNG CANCER SYMPOSIUM
Program update
| The 2nd WJTOG International Symposium on Lung Cancer Clinical Trial | |||
| "July 6-July 8,NARA Prefectural New Public Hall" | |||
| AGENDA | |||
| "Thursday, July 6" | |||
| 10:00-16:00 | Excursion to Horyuji-Temple | ||
| 18:00-19:00 | Keynote Address | (Nikko Nara Hotel) |
|
| Chairperson | Nagahiro Saijo | ||
| National Cancer Center Hospital East | |||
| Speaker | David H. Johnson | ||
| Vanderbilt-Ingram Cancer Center | |||
| 19:00-21:00 | Welcome Party | Nikko Nara Hotel | |
| "Friday, July 7" | |||
| 9:00-9:15 | Opening Remark and Introduction | ||
| WJTOG | Masahiro Fukuoka | ||
| "Kinki University School of Medicine, Sakai Hospital" | |||
| 9:15 | Session I Molecular Targeted Therapy in Metastatic NSCLC | ||
| I-1 | Clinical trial of EGFR-TKI | ||
| Chairperson | Rafael Rosell | ||
| Hospital Germans Trias I Pujol | |||
| Yoichi Nakanishi | |||
| Kyushu University Graduate School of Medical Sciences | |||
| 9:15-9:35 | Title | US Trials with Molecular Targeted Therapy | |
| Speaker | Everett E. Vokes | ||
| University of Chicago | |||
| 9:35-9:45 | Title | Prospective and Retrospective Study of Gefitinib in WJTOG (WJTOG0203A&0403) | |
| Speaker | Kenji Tamura | ||
| Kinki University School of Medicine, Nara Hospital | |||
| 9:45-10:00 | Title | Korean Clinical Trials with Molecular Targeted Therapy | |
| Speaker | Jin Soo Lee | ||
| National Cancer Center Korea | |||
| 10:00-10:30 | Discussion | ||
| Discussant | Ikuo Sekine | ||
| National Cancer Center Hospital Tokyo | |||
| I-2 | Biomarker & Clinical Trial | ||
| Chairperson | Giorgio V. Scagliotti | ||
| University of Torino | |||
| Hirotoshi Akita | |||
| Hokkaido University Graduate School of Medicine | |||
| 10:30-10:45 | Title | Gefitinib and EGFR Mutations | |
| Speaker | Tetsuya Mitsudomi | ||
| Aichi Cancer Center Hospital | |||
| 10:45-11:05 | Title | Biomarker & Clinical Trial | |
| Speaker | Rafael Rosell | ||
| Hospital Germans Trias i Pujol | |||
| 11:05-11:35 | Discussant | Kazuto Nishio | |
| Kinki University School of Medicine | |||
| I-3 | New Molecurar Targeted Agents for Lung Cancer | ||
| Chairperson | Noriyuki Masuda | ||
| Kitasato University School of Medicine | |||
| Everett E. Vokes | |||
| University of Chicago | |||
| 11:35-11:55 | Title | ECOG Trials with Molecular Targeted Agents (Avastin) | |
| David H. Johnson | |||
| Vanderbilt-Ingram Cancer Center | |||
| 11:55-12:15 | Title | New Molecular Targeted Agents for Lung Cancer | |
| David R. Gandara | |||
| University of California Davis Cancer Center | |||
| 12:15-12:45 | Discussant | Tomohide Tamura | |
| National Cancer Center Hospital Tokyo | |||
| 12:45-13:45 | Lunch | ||
| 13:50-14:45 | Educational Lecture | ||
| Chairperson | Harubumi Kato | ||
| Tokyo Medical University | |||
| Title | Current Topics of Pathology in Lung Cancer | ||
| Speaker | William D.Travis | ||
| Memorial Sloan Kettering Cancer Center | |||
| 14:45-15:00 | Break | ||
| Section Meeting | |||
| Section Meeting1 | |||
| 1-1 | BAC & BAC Feature | ||
| Chairperson | William D. Travis | ||
| Memorial Sloan Kettering Cancer Center | |||
| Hisao Asamura | |||
| National Cancer Center Hospital | |||
| 15:00-15:20 | Title | Pathological Concept of BAC | |
| Speaker | Masayuki Noguchi | ||
| Tsukuba University School of Medicine | |||
| 15:20-15:35 | Title | Radiologic and Pathologic Correlations in Small Adenocarcinoma of The Lung | |
| Speaker | Kenji Suzuki | ||
| National Cancer Center Hospital Tokyo | |||
| 15:35-16:05 | Discussion | ||
| Discussant | Riichiro Maruyama | ||
| Nippon Steel Yawata Memorial Hospital | |||
| 1-2 | Clinical Trials for BAC and BAC Feature | ||
| Chairperson | Jin Soo Lee | ||
| National Cancer Center Korea | |||
| Minoru Takada | |||
| NHO Kinki Cest Medical Center | |||
| 16:05-16:20 | Title | SWOG Trials for Patients with BAC | |
| Speaker | David R. Gandara | ||
| University of California Davis Cancer Center | |||
| 16:20-16:35 | Title | Clinical Trials for Patients with BAC in Europe | |
| Speaker | Giorgio V. Scagliotti | ||
| University of Torino | |||
| 16:35-17:05 | Discussion | ||
| Discussant | Junya Fukuoka | ||
| Toyama University Hospital | |||
| Section Meeting 2 | |||
| The role of PET for Clinical Trials | |||
| Chairperson | Hak Choy | ||
| University of Texas Southwestern Medical Center | |||
| Kenji Eguchi | |||
| Tokai University School of Medicine | |||
| 15:00-15:20 | PET in Resectable NSCLC | ||
| Title | Current position of PET on Resectable NSCLC | ||
| Speaker | Joe B. Putnam | ||
| Vanderbilt University Medical Center | |||
| 15:20-15:50 | Discussion | ||
| Discussant | Takashi Seto | ||
| National Kyushu Cancer Center | |||
| 2-2 | PET in Unresectable NSCLC | ||
| 15:50-16:10 | Title | PET in RTOG Clinical Trial for Stage III NSCLC | |
| Speaker | William T. Sause | ||
| LDS Hospital | |||
| 16:10-16:30 | Title | Current Clinical Status of PET in Europe | |
| Speaker | Rafael Rosell | ||
| Hospital Germans Trias I Pujol | |||
| 16:30-17:00 | Discussion | ||
| Discussant | Seiji Niho | ||
| National Cancer Center Hospital East | |||
| 17:30-18:20 | Japanese Lyrical Noh Drama （to be planned) | ||
| 18:30-20:30 | Garden party | ||
| Kenji Tamura | |||
| Ji-ichiro Sasaki | |||
| "Saturday, July 8" | |||
| Session� | |||
| II-1 Chemo-radiotherapy for Locally Advanced NSCLC | |||
| Chairperson | Kazushige Hayakawa | ||
| Kitasato University School of Medicine | |||
| Yasumasa Nishimura | |||
| Kinki University School of Medicine | |||
| II-1-1 | Chemotherapy Regimen and Schedule | ||
| 9:00-9:20 | Title | Clinical Trials for Locally Advanced NSCLC in USA | |
| Speaker | William T. Sause | ||
| LDS Hospital | |||
| 9:20-9:35 | Title | Japanese Trials | |
| Speaker | Nobuyuki Yamamoto | ||
| Shizuoka Cancer Center | |||
| 9:35-10:05 | Discussion | ||
| Discussant | Katsuyuki Kiura | ||
| Okayama University Graduate School of Medicine and Dentistry | |||
| II-1-2 | RT Technology: Dose and Schedule | ||
| 10:05-10:20 | Title | Dose and Schedule of RT in Locally Advanced NSCLC (WJTOG3305) | |
| Speaker | Takuhito Tada | ||
| Osaka City University Medical School | |||
| 10:20-10:40 | Title | Current Status of RT Technology in USA | |
| Speaker and Discussant | Hak Choy | ||
| University of Texas Southwestern Medical Center | |||
| 10:40-11:00 | Discussion | ||
| II-2 Molecular Targeted Therapy for Locally Advanced NSCLC | |||
| Chairperson | William T. Sause | ||
| LDS Hospital | |||
| Satoshi Ishikura | |||
| National Cancer Center Hospital East | |||
| II-2-1 | EGFR-TKIs | ||
| 11:00-11:20 | Title | SWOG0023 | |
| Speaker | David H. Gandara | ||
| University of California Davis Cancer Center | |||
| 11:20-11:35 | Title | JOCG Trials of Gefitinib in Combination with RT | |
| Speaker | Yuichiro Ohe | ||
| National Cancer Center Hospital Tokyo | |||
| 11:35-12:05 | Discussion | ||
| Discussant | Isamu Okamoto | ||
| Kinki University School of Medicine | |||
| II-2-2 | EGFR/VEGF Antibodies | ||
| 12:05-12:25 | Title | Clinical Trials of EGFR/VEGF Ab in Combination with RT | |
| Speaker | Hak Choy | ||
| University of Texas Southwestern Medical Center | |||
| 12:25-12:55 | Discussion | ||
| Discussant | Kaoru Kubota | ||
| National Cancer Center Hospital East | |||
| 12:55-14:00 | Lunch | ||
| SessionIII Peri-operative Chemotherapy in Early Stage NSCLC | |||
| III-1 | Clinical Imprecations of CALGB 9633 | ||
| Chairperson | Haruhiko Kondo | ||
| Shizuoka Cancer Center | |||
| Joe B. Putnam | |||
| Vanderbilt University Medical Center | |||
| 14:00-14:15 | Title | CALGB Trials in Early Stage NSCLC | |
| Speaker | Everett E. Vokes | ||
| University of Chicago | |||
| 14:15-14:25 | Comment | Haruhiko Fukuda | |
| National Cancer Center Hospital Tokyo | |||
| 14:25-14:50 | Discussion | ||
| Discussant | Hideo Kunitoh | ||
| National Cancer Center Hospital Tokyo | |||
| III-2 | Adjuvant Chemotherapy in Early Stage NSCLC | ||
| Chairperson | Jin Soo Lee | ||
| National Cancer Center Korea | |||
| Kohei Yokoi | |||
| Nagoya University School of Medicine | |||
| 14:50-15:10 | Title | Current US Trials in Early Stage NSCLC | |
| Speaker | Joe B. Putnam | ||
| Vanderbilt University Medical Center | |||
| 15:10-15:30 | Title | Current Status of Adjuvant Chemotherapy in Early Stage NSCLC in Europe | |
| Speaker | Giorgio V. Scagliotti | ||
| University of Torino | |||
| 15:30-15:45 | Title | Japanese Adjuvant Trial in Early Stage NSCLC | |
| Speaker | Hirohito Tada | ||
| Osaka City General Hospital | |||
| 15:45-16:15 | Discussion | ||
| Discussant | Masahiro Tsuboi | ||
| Tokyo Medical University | |||
| III-3 | Preoperative Chemotherapy in Early Stage NSCLC | ||
| Chairperson | Yukito Ichinose | ||
| National Kyushu Cancer Center | |||
| David R. Gandara | |||
| University of California Davis Cancer Center | |||
| 16:15-16:30 | Title | A Randomized Phase III Trial of Preoperative Chemotherapy vs Chemoradiotherapy for Patients with Stage IIIA ,N2 Non-small Cell Lung Cancer. A Preliminary Report. | |
| Speaker | Nobuyuki Katakami | ||
| Kobe City General Hospital | |||
| 16:30-16:45 | Title | NATCH Trial | |
| Speaker | Rafael Rosell | ||
| Hospital Germans Trias i Pujol | |||
| 16:45-17:15 | Discussion | ||
| Discussant | Takayasu Kurata | ||
| Hyogo Medical Center for Adults | |||
| 17:15-17:35 | Summary and Closing Remarks | ||
| WJTOG | Kazuhiko Nakagawa | ||
| Kinki University School of Medicine | |||
6th - 8th,July, 2006
NARA CITY, JAPAN
NARA Prefectural New Public Hall
http://www.pref.nara.jp/koukaido-e/
Congress place : NARA Prefectural New Public Hall - traditonal japanese style
NARA city is the Japanese ancient metropolis, most famous historical area.
NARA City view from WAKAKUSA mountain.
